Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

420.21p
   
  • Change Today:
    -4.80p
  • 52 Week High: 435.00
  • 52 Week Low: 270.00
  • Currency: UK Pounds
  • Shares Issued: 47.78m
  • Volume: 25,377
  • Market Cap: £200.79m
  • RiskGrade: 180
  • Beta: 0.29

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Matthew (Matt) Giovanni Sassone
CFO: Anna Wasyl
Executive Director: Bart Leemans
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Director: Isabel J S Napper
Non-Executive Dir: Tom Jenkins

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 420.21p
Change Today -4.80p
% Change -1.13 %
52 Week High 435.00
52 Week Low 270.00
Volume 25,377
Shares Issued 47.78m
Market Cap £200.79m
Beta 0.29
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average
Price Trend
2.37% below the market average2.37% below the market average2.37% below the market average2.37% below the market average2.37% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income
19.27% above the market average19.27% above the market average19.27% above the market average19.27% above the market average19.27% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
85.58% above the market average85.58% above the market average85.58% above the market average85.58% above the market average85.58% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Nov-25 20-Mar-25
Paid 18-Dec-25 11-Apr-25
Amount 8.52p 5.68p

Trades for 19-Dec-2025

Time Volume / Share Price
15:47 180 @ 421.30p
15:45 2,358 @ 423.80p
14:35 234 @ 424.00p
14:19 1 @ 425.00p
14:19 31 @ 425.00p

Tristel Key Personnel

CEO Matthew (Matt) Giovanni Sassone
CFO Anna Wasyl

Top of Page